Skip to main content

Table 4 Comparing management of ascites in subjects with peritoneal carcinomatosis and subjects with portal hypertension

From: Clinical characteristics and outcomes in those with primary extrahepatic malignancy and malignant ascites

Management

Peritoneal carcinomatosis

Portal hypertension

P value

Diuretics

31/150 (21%)

8/69 (11%)

0.13

Paracentesis

35/150 (23%)

18/69 (26%)

0.73

Peritoneal drain

31/150 (21%)

20/69 (29%)

0.23

Shunt

1/150 (0.7%)

0/69 (0%)

1

Chemotherapy/Immunotherapy*

52/150 (35%)

23/69 (33%)

0.88

  1. *These patients only received chemotherapy or immunotherapy while the others represented in this table received chemotherapy or immunotherapy in addition to the stated therapy